Androgenetic Alopecia: Clinical Aspects and Treatment



Diffuse loss of scalp hair, even when no scars are left behind, has always been felt to constitute the loss of a major cosmetic attribute. In some cultures and for millions of people, hair represents the crown of beauty.


Hair Follicle Hair Growth Scalp Hair Alopecia Areata Hair Shaft 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Achten G, Wannet-Rouard J (1971) Trichogramme et medecine légale. Arch Belg Derm Syph 27:353–359PubMedGoogle Scholar
  2. Adachi K (1973) The metabolism and control mechanism of human hair follicles. Curr Probi Dermatol 5:37–78Google Scholar
  3. Allegra F (1968) Histology and histochemical aspects of the hair follicles in pattern alopecia. In: Baccaredda-Boy A, Moretti G, Frey JR (eds) Biopathology of pattern alopecia. Karger, Basel, pp 107–128Google Scholar
  4. Aram H (1987) Treatment of female androgenetic alopecia with Cimetidine. Intern J Derm 26:128–130CrossRefGoogle Scholar
  5. Baden HP, Kubilus J (1983) Effect of minoxidil on cultured keratinocytes. J Invest Dermatol 81:558–560PubMedCrossRefGoogle Scholar
  6. Baral J (1985) Scalp comedones after topical minoxidil. J Am Acad Dermatol 13:1051PubMedCrossRefGoogle Scholar
  7. Barman JM, Astore J, Pecoraro V (1965) The normal trichogram of the adult. J Invest Dermatol 44:233–236PubMedGoogle Scholar
  8. Barman JM, Astore J, Pecoraro V (1967) The normal trichogram of people over 50 years but apparently not bald. In: Montagna W, Dobson R (eds) Advances in biology of skin hair growth. Pergamon, Oxford, pp 211–220Google Scholar
  9. Barnes EW, Irvine WJ, Hunter WM, Ismail AAA (1975) Cyproterone acetate: a study involving two volunteers with idiopathic hirsutism. Clin Endocrinol 4:65–73CrossRefGoogle Scholar
  10. Bassas E, Pinto E (1974) Experimental study on male pattern alopecia. Arch Dermatol Forsch 248:339–346PubMedCrossRefGoogle Scholar
  11. Bazzano GS, Terezakis N, Galen W (1986) Topical tretinoin for hair growth promotion. J Am Acad Dermatol 15:880–893PubMedCrossRefGoogle Scholar
  12. Beek CH (1950) A study on extension and distribution of the human body-hair. Dermatologica 101:317–333PubMedCrossRefGoogle Scholar
  13. Behrman HT (1952) The scalp in health and disease. Mosby, St. Louis, pp 173–183Google Scholar
  14. Belaube B, Devaux J, Gamby T, Garcin G, Privat Y (1982) Place de l’hormonotherapie dans le traitement de l’acné, de l’hirsutisme idiopathique et des alopécies seborrheiques. Sem Hop Paris 58:1650–1653PubMedGoogle Scholar
  15. Bingham KD, Shaw DA (1973) The metabolism of testosterone by human scalp skin. J Endocrinol 57:111–121PubMedCrossRefGoogle Scholar
  16. Bouton MM, Lecaque D, Secchi J, Tournemine C (1986) Effect of a new, topically active antiandrogen (RU 38882) on the rat sebaceous gland: comparison with cyproterone acetate. J Invest Dermatol 86:163–167PubMedCrossRefGoogle Scholar
  17. Braendle W, Boess H, Breckwoldt M, Leven Ch, Bettendorf G (1974) Wirkung und Nebenwirkung von Cyproteronazetat-Behandlung. Arch Gynäkol 216:335–345PubMedCrossRefGoogle Scholar
  18. Braun-Falco O, Heilgemeir GP (1977) Aussage der Haarwurzelstatusmethode. Hautarzt 28:136–139Google Scholar
  19. Burke GM, Cunliffe WJ (1985) Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia. Br J Dermatol 112:124–125PubMedCrossRefGoogle Scholar
  20. Burton JL, Marshall A (1979) Hypertrichosis due to minoxidil. Br J Dermatol 101:593–595PubMedCrossRefGoogle Scholar
  21. Burton JL, Schutt WH, Caldwell IW (1975) Hypertrichosis due to diazoxide. Br J Dermatol 93:707–711PubMedCrossRefGoogle Scholar
  22. Burton JL, Ben Halim MM, Meyrick G, Jeans WD, Murphy D (1979) Male-pattern alopecia and masculinity. Br J Dermatol 100:567–571PubMedCrossRefGoogle Scholar
  23. Cipriani R, Ruzza G, Foresta G (1983) Sex hormone binding globulin and saliva testosterone levels in men with androgenetic alopecia. Br J Dermatol 109:249–252PubMedCrossRefGoogle Scholar
  24. Cohen RL, Alves MEAF, Weiss VC et al. (1984) Direct effects of minoxidil on epidermal cells in culture. J Invest Dermatol 82:90–93PubMedCrossRefGoogle Scholar
  25. Crovato F, Moretti G, Bertamino R (1968) Histochemistry of dermis and blood vessels in male pattern alopecia. In: Baccaredda-Boy A, Moretti G, Frey JR (eds) Biopathology of pattern alopecia. Karger, Basel, pp 191–199Google Scholar
  26. Crovato F, Moretti G, Bertamino R (1973) 17-beta-hydroxysteroid-dehydrogenases in hair follicles of normal and bald scalp: a histochemical study. J Invest Dermatol 60:126–133PubMedCrossRefGoogle Scholar
  27. Cumming DC, Yang JC, Rebar RW, Yen SSC (1982) Treatment of hirsutism with spironolactone. JAMA 247:1295–1298PubMedCrossRefGoogle Scholar
  28. Dargie HJ, Dollery CT, Daniel J (1977) Minoxidil in resistant hypertension. Lancet 11:515–518CrossRefGoogle Scholar
  29. Dawber RPR, Sonnex T, Ralfs I (1982) Oral antiandrogen treatment in women. Br J Dermatol 107, Suppl 22:20Google Scholar
  30. De Boer EM, Bezemer PD, Bruynzeel DP, Nieboer C (1988) Does topical minoxidil increase skin blood flow? A laser Doppler flowmetry study. Acta Derm Venereol 68:271–274PubMedGoogle Scholar
  31. De Graf H, Hendrickx I, Dooms-Goossens A (1985) Allergic contact dermatitis to minoxidil. Contact Dermatitis 13:194–195CrossRefGoogle Scholar
  32. De Villez RL (1985) Topical minoxidil therapy in hereditary androgenetic alopecia. Arch Dermatol 121:197–202PubMedCrossRefGoogle Scholar
  33. De Villez RL, Dunn J (1986) Female androgenic alopecia. Arch Dermatol 122:1011–1015PubMedCrossRefGoogle Scholar
  34. Dijkstra AC, Goos MAA, Cunliffe WJ (1987) Is increased 5a-reductase activity a primary phenomenon in androgen-dependent skin disorders? J Invest Dermatol 89:87–92PubMedCrossRefGoogle Scholar
  35. Ebling F J (1973) The effects of cyproterone acetate and oestradiol upon testosterone stimulated sebaceous activity in the rat. Acta Endocrinol (Copenhagen) 72:361–365Google Scholar
  36. Ebling F J, Thomas AK, Cooke ID, Randall VA, Skinner J, Cawood M (1977) Effect of cyproterone acetate on hair growth, sebaceous secretion and endocrine parameters in a hirsute subject. Br J Dermatol 97:371–381PubMedCrossRefGoogle Scholar
  37. Eckert J (1975) Diffuse hair loss and psychiatric disturbances. Acta Dermatol 55:147–149Google Scholar
  38. Eckert J, Church RE, Ebling F J, Munro DS (1967) Hair loss in women. Br J Dermatol 79:543–548PubMedCrossRefGoogle Scholar
  39. Editorial (1986) Unapproved use of minoxidil. J Am Acad Dermatol 14:828–829CrossRefGoogle Scholar
  40. Eil CH, Edelson SK (1984) The use of human skin fibroblasts to obtain potency estimates of drug binding to androgen receptors. J Clin Endocrinol Metabol 59:51–55CrossRefGoogle Scholar
  41. Ekoe TM, Burchardt P, Reredi B (1980) Treatment of hirsutism, acne and alopecia with cyproterone acetate. Dermatológica 160:338–345Google Scholar
  42. Emons G, Diedrich K, Krebs D, Knuppen R (1984) Postmenopausenblutung nach Anwendung eines östrogenhaltigen Haarwassers — begleitende endokrine Veränderungen. Geburtsh Frauenheilkd 44:460–462CrossRefGoogle Scholar
  43. Feinstein R (1985) The effect of topical minoxidil on blood pressure. J Am Acad Dermatol 13:673–674PubMedCrossRefGoogle Scholar
  44. Fenton DA, English JS, Wilkinson JD (1982) Reversal of male pattern baldness, hypertrichosis and accelerated hair and nail growth in patients receiving benoxaprofen. Br Med J 284:1228–1230Google Scholar
  45. Ferrari RA, Chakrabarty K, Beyler AL, Wiland J (1978) Suppression of sebaceous glands in laboratory animals by 17a-propyltestosterone. J Invest Dermatol 71:320–323PubMedCrossRefGoogle Scholar
  46. Fiedler-Weiss VC, West DP, Buys CM, Rumsfield JA (1986) Topical minoxidil dose-response effect in alopecia areata. Arch Dermatol 122:180–182PubMedCrossRefGoogle Scholar
  47. Fiedler VC, Buys CM (1987) Immunohistochemical characterization of the cellular infiltrate in severe alopecia areata before and after minoxidil treatment. Dermatológica 175, Suppl 2:29–35PubMedCrossRefGoogle Scholar
  48. Franz TJ (1985) Percutaneous absorption of minoxidil in man. Arch Dermatol 121:203–206PubMedCrossRefGoogle Scholar
  49. Futterweit W (1984) Pathophysiology of polycystic ovarian disease. In: Futterweit W (ed) Polycystic ovarian disease. Springer, Berlin Heidelberg New York, pp 49–82CrossRefGoogle Scholar
  50. Futterweit W, Dunait A, Hsu-Chong Yeh, Kingsley P (1988) The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia. J Am Acad Derm 19:831–836PubMedCrossRefGoogle Scholar
  51. Georgala G, Papasotiriou V, Stavropoulos P (1986) Serum testosterone and sex hormone binding globulin levels in women with androgenetic alopecia. Acta Derm Venereol 66:532–534PubMedGoogle Scholar
  52. Giacometti L, Montagna W (1968) The nerve fibers in male pattern alopecia. In: Baccaredda-Boy A, Moretti G, Frey JR (eds) Biopathology of pattern alopecia. Karger, Basel, pp 208–215Google Scholar
  53. Gibbons RD, Fiedler-Weiss VC, West DP, Lapin G (1986) Quantification of scalp hair — a computer-aided methodology. J Invest Dermatol 86:78–82PubMedCrossRefGoogle Scholar
  54. Gilliland JM, Kirk J, Smeaton TC (1981) Normalized androgen ratio: its application in clinical dermatology. Clin Exper Dermatol 6:349–353CrossRefGoogle Scholar
  55. Green MR, Couchman JR (1984) Distribution of epidermal growth factor receptors in rat tissues during embryonic skin development, hair formation, and the adult hair growth cycle. J Invest Dermatol 83:118–123PubMedCrossRefGoogle Scholar
  56. Grosshans E, Chepfer MP, Maleville J (1972) Le trichogramme. A propos d’une méthode d’étude des cheveux. J Med Strasbourg 2:378–384Google Scholar
  57. Groveman HD, Ganiats T, Klauber MR (1985) Lack of efficacy of polysorbate 60 in the treatment of male pattern baldness. Arch Intern Med 145:1454–1458PubMedCrossRefGoogle Scholar
  58. Guy WB, Edmundsen WF (1960) Diffuse cyclic hair loss in women. Arch Dermatol 81:205–207PubMedCrossRefGoogle Scholar
  59. Hamilton JB (1942) Male hormone stimulation is prerequisite and an incitant in common baldness. Am J Anat 71:451–480CrossRefGoogle Scholar
  60. Hamilton JB (1951) Patterned loss of hair in man; types and incidence. Ann NY Acad Sci 53:708–728PubMedCrossRefGoogle Scholar
  61. Hammerstein J, Meckies J, Leo-Rossberg I, Moltz L, Zielske F (1975) Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism. J Steroid Biochem 6:827–836PubMedCrossRefGoogle Scholar
  62. Harris H (1946) The inheritance of premature baldness in man. Ann Eugenics 13:172CrossRefGoogle Scholar
  63. Hay JB (1977) A study of the in vitro metabolism of androgens by human scalp and pubic skin. Br J Dermatol 97:237–246PubMedCrossRefGoogle Scholar
  64. Headington JT (1987) Hair follicle biology and topical minoxidil: possible mechanisms of action. Dermatologica 175, Suppl 2:19–22PubMedCrossRefGoogle Scholar
  65. Headington JT, Novak E (1984) Clinical and histologic studies of male pattern baldness with topical minoxidil. Curr Ther Res 36:1098–1106Google Scholar
  66. Hertel H, Gollnick H, Matthies C, Baumann I, Orfanos CE (1988) Low dose retinol and L-cystin improve alopecia of diffuse type after long-term oral application. In: Orfanos CE, Stadler R, Gollnick H (eds) Dermatology in five continents. Springer, Berlin Heidelberg New York, pp 1164–1167Google Scholar
  67. Hoffmann E, Meirs HG, Hubbes A (1974) Wirkungen von Antikonzeptiva auf Alopecia androgenetica, Seborrhoea oleosa, Akne vulgaris und Hirsutismus. Dtsch Med Wschr 99:2151–2157PubMedCrossRefGoogle Scholar
  68. Hori H, Moretti G, Rebora A, Crovato F (1972) The thickness of human scalp: normal and bald. J Invest Dermatol 58:396–399PubMedCrossRefGoogle Scholar
  69. Jackson D, Church RE, Ebling FJ (1972) Hair diameter in female baldness. Br J Dermatol 87:361–367PubMedCrossRefGoogle Scholar
  70. James KC, Rushton DH (1983) Evaluation techniques for male pattern baldness. J Am Acad Dermatol 14:849–850CrossRefGoogle Scholar
  71. Jenkins JS, Ash S (1973) The metabolism of testosterone by human skin in disorders of hair growth. J Endocrinol 59:345–351PubMedCrossRefGoogle Scholar
  72. Jost B, Meiers HG, Schmidt-Eimendorff H, Pfaffenrath V (1974) Trichometrische Quantifizierung und Verlaufsbeurteilung des Hirsutismus. Dtsch Med Wschr 99:2395–2400PubMedCrossRefGoogle Scholar
  73. Kaiser E (1984) Wirkung eines neuen hormonalen Antikonzeptivums (Neo-Eunomin) bei Frauen mit Androgenisierungserscheinungen. Geburtsh Frauenheilkd 44:651–655CrossRefGoogle Scholar
  74. Kaszynski E (1983) The stimulation of hair growth in the flank organs of female hamsters by subcutaneous testosterone propionate and its inhibition by topial cyproterone acetate: doseresponse studies. Br J Dermatol 109:565–569PubMedCrossRefGoogle Scholar
  75. Kolb KH, Schulze PE (1971) Über die kutane Penetration von Sexualsteroidhormonen. Symp Dtsch Ges Endocrinol 17, Springer, Berlin Heidelberg New York, pp 49–56Google Scholar
  76. Kuester W, Happle R (1984) The inheritance of common baldness: two B or not two B? J Am Acad Dermatol 11:921–926CrossRefGoogle Scholar
  77. Kuhlwein A (1985) Androgene Alopecie vom weiblichen Typ beim Mann. Z Hautkr 60:576–578PubMedGoogle Scholar
  78. Lattanand A, Johnson WC (1975) Male pattern alopecia. A histopathologic study. J Cutan Pathol 2:58–70PubMedCrossRefGoogle Scholar
  79. Lester Gabrilove J, Luria M (1978) Persistent gynecomastia resulting from scalp injunction of estradiol. Arch Dermatol 114:1672–1673CrossRefGoogle Scholar
  80. Lobo RA, Shoupe D, Serafini P, Brinton D, Horton R (1985) The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women. Fert Steril 43:200–205Google Scholar
  81. Lookingbill DP, Horton R, Demers LM, Egan N, Marks JG, Santen RJ (1985) Tissue production of androgens in women with acne. J Am Acad Dermatol 12:481–487PubMedCrossRefGoogle Scholar
  82. Lucky AW, McGuire J, Nydorf E, Halpert G, Nuck BA (1986) Hair follicle response of the golden Syrian hamster flank organ to continuous testosterone stimulation using silastic capsules. J Invest Dermatol 86:83–86PubMedCrossRefGoogle Scholar
  83. Luderschmidt C, Eiermann W, Jawny J, Bidlingmaier F, Ring J (1984) 17a-propylmesterolone (Sch 434): an antiandrogenic sebosuppressive substance not influencing circulating testosterone concentrations. Naunyn-Schmiedeberg’s Arch Pharmacol 328:214–216CrossRefGoogle Scholar
  84. Ludwig E (1964) Die androgenetische Alopezie bei der Frau. Arch Klin Exp Dermatol 219:558–564PubMedCrossRefGoogle Scholar
  85. Ludwig E (1977) Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 97:247–254PubMedCrossRefGoogle Scholar
  86. Lutsky BN, Budak M, Koziol P, Monahan M, Neri RO (1975) The effects of a nonsteroid antiandrogen, flutamide, on sebaceous gland activity. J Invest Dermatol 64:412–117PubMedCrossRefGoogle Scholar
  87. Maguire HC, Kligman AM (1962) The histopathology of common male baldness. In: Proceedings of the Xllth International Congress of Dermatology, Washington. Excerpta Medica, Amsterdam, p 1438Google Scholar
  88. Maguire HC, Kligman AM (1964) Hair plucking as a diagnostic tool. J Invest Dermatol 43:77–79Google Scholar
  89. Maibach HI, Feldmann R, Payne B, Hutshell T (1968) Scalp and forehead sebum production on male patterned alopecia. In: Baccaredda-Boy A, Moretti G, Frey JR (eds) Biopathology of pattern alopecia. Karger, Basel, pp 171–176Google Scholar
  90. Matias JR, Orentreich N, Malloy V, De Feo CP, Matias L (1984) The lack of effect of lla-hydroxyprogesterone on the flank organ and ear sebaceous glands in adult male Syrian golden hamsters. Arch Dermatol Res 276:346–348PubMedCrossRefGoogle Scholar
  91. Maurer C, von Seebach HB, Loskant G (1983) Uterine Blutung im Senium nach Langzeitanwendung östrogenhaltigen Haarwassers. Dt Med Wschr 108:1097–1099CrossRefGoogle Scholar
  92. Meiers HG (1975) Trichogramm (= Haarwurzelstatus, = Haarbild). Methode und Aussagefähigkeit. Akt Dermatol 1:31–32Google Scholar
  93. Meiers HG, Grobbel B (1974) Das Kopfhaar im Alter. Z Geront 7:427–30Google Scholar
  94. Meiers HG, Rechenberger HG, Rechenberger J (1973) Trichotillomanie. Untersuchungen zur Ätiologie, Diagnostik und Therapie. Hautarzt 24:248–252PubMedGoogle Scholar
  95. Meisheri KD, Cipkem LA (1987) Biochemical mechanisms by which minoxidil sulfate influences mammalian cells. Dermatologica 175, Suppl 2:3–11PubMedCrossRefGoogle Scholar
  96. Metz HG, Landes E (1970) Der Haarausfall und seine Untersuchung. Fortschr Med 88:1327–1328Google Scholar
  97. Miller JA, Darley CR, Karkavitsas K, Kirby JD, Munro DD (1982) Low sex-hormone binding globulin levels in young women with diffuse hair loss. Br J Dermatol 106:331–336PubMedCrossRefGoogle Scholar
  98. Miyazaki M, Takayasu S, Karakawa T, Aono T, Kurachi K, Matsumoto K (1978) Activity of testosterone 5a-reductase in the hair follicles of women with polycystic ovaries. J Endocr 78:445–446PubMedCrossRefGoogle Scholar
  99. Moltz L, Haase F, Schwartz U, Hammerstein J (1983) Die Behandlung androgenisierter Frauen mit intramuskulär applizierbarem Cyproteronacetat. Geburtsh Frauenheilkd 43:281–287CrossRefGoogle Scholar
  100. Moltz L, Schwartz U, Sörensen R, Pickartz H, Hammerstein J (1984) Ovarian and adrenal vein steroids in patients with nonneoplastic hyperandrogenism: selective catheterization findings. Fert Steril 42:69–75Google Scholar
  101. Morales-Alanis H, Brienne MJ, Jacques J, Bouton MM, Nedelec L, Torelli V, Tournemine C (1985) Antiandrogenic activity of a series of Des-A-steroid derivatives. J Med Chem 28:1796–1803PubMedCrossRefGoogle Scholar
  102. Mortimer CH, Rushton H, James KC (1984) Effective medical treatment for common baldness in women. Clin Exp Dermatol 9:342–350PubMedCrossRefGoogle Scholar
  103. Muller SA (1973) Alopecia. Syndromes of genetic significance. J Invest Dermatol 60:475–492PubMedCrossRefGoogle Scholar
  104. Neale C, Krebs D, Bettendorf G (1971) Behandlung der Akne, des Hirsutismus und der Alopezie mit Cyproteronazetat und Äthinylöstradiol. Acta Endocrin (Kopenhagen) 66, Suppl 152:13Google Scholar
  105. Neumann F, Elger DVM (1966) The effect of a new antiandrogenic steroid, 6-chloro-17-hydroxy-la,2-methylenepregna-4,6-diene-3,20-dione acetate (cyproterone acetate) on the sebaceous glands of mice. J Invest Dermatol 46:561–573Google Scholar
  106. Nielsen PG (1982 a) Treatment of idiopathic hirsutism with spironolactone. Dermatologica 165:194–196CrossRefGoogle Scholar
  107. Nielsen PG (1982 b) Treatment of moderate idiopathic hirsutism with a cream containing can-renone (an antiandrogen). Dermatologica 165:636–639CrossRefGoogle Scholar
  108. Nietzschmann F (1982) Lokale Östrogenapplikation bei androgenetischer Alopezie. Dissertation, Freie Universität, BerlinGoogle Scholar
  109. Nuck BA, Lucky AW (1987) Epitestosterone: a potential new antiandrogen. J Invest Dermatol 89:209–211PubMedCrossRefGoogle Scholar
  110. Nuck BA, Fogelson S, Lucky AW (1987) Topical minoxidil does not act as an antiandrogen in the flank organ of the golden Syrian hamster. Arch Dermatol 123:59–61PubMedCrossRefGoogle Scholar
  111. Olsen EA, Weiner SM, Delong ER, Pinell SR (1985) Topical minoxidil in early male pattern baldness. J Am Acad Dermatol 13:185–192PubMedCrossRefGoogle Scholar
  112. Olsen EA, Delong ER, Weiner MS (1986) Dose-response study of topical minoxidil in male pattern baldness. J Am Acad Dermatol 15:30–37PubMedCrossRefGoogle Scholar
  113. Orentreich N (1959) Autographs in alopecias and other selected dermatological conditions. Ann NY Acad Sci 83:463–79PubMedCrossRefGoogle Scholar
  114. Orentreich N (1960) Pathogenesis of alopecia. J Soc Cosm Chem 11:479–199Google Scholar
  115. Orfanos CE, Brückner L (1982) Messungen der Haardichte anormaler menschlicher Kopfhaut mit und ohne kosmetische Vorbehandlung. Akt Dermatol 8:222–224Google Scholar
  116. Orfanos CE, Hertel H (1988) Haarwachstumsstörungen bei Hyperprolaktinämie. Z Hautkr 63:23–26PubMedGoogle Scholar
  117. Orfanos CE, Vogels L (1980) Lokaltherpaie der alopecia androgenetic mit 17alpha-Oestradiol. Eine kontrollierte, randomisierte Doppelblindstudie. Dermatologica 161:124–132PubMedCrossRefGoogle Scholar
  118. Orfanos CE, Wüstner H (1975) Penetration und Nebenwirkungen lokaler Östrogenapplikation bei Alopecia androgenetica. Hautarzt 26:367–369PubMedGoogle Scholar
  119. Orfanos CE, Meiers HG, Friederich HC, Ludwig E, Mahrle G, Zaun H (1974) Haarausfall, Trichogramm und hormonelle Haartherapeutica. Dtsch Ärztbl 3603–3608Google Scholar
  120. Panteleos D, Orfanos CE (1976) Die Aufnahme und therapeutische Anwendung von lokal appliziertem Östrogen. Ärztl Kosmetol 6:159–163Google Scholar
  121. Papa CM, Kligman AM (1965) Stimulation of hair growth by topical application of androgens. J Am Med Assoc 191:521–525CrossRefGoogle Scholar
  122. Passchier J, van der Donk J, Dutree-Meulenberg ROGM, Stolz E, Verhage F (1988) Psychological characteristics of men with androgenetic alopecia and effects of treatment with topical minoxidil. Int J Dermatol 27, Suppl 6:441–46CrossRefGoogle Scholar
  123. Pecoraro V, Astore J, Barman J, Araujo CS (1964) The normal trichogram in the child before the age of puberty. J Invest Dermatol 42:427–130PubMedGoogle Scholar
  124. Peereboom-Wynia JDR, Beek CH (1977) The influence of cyproterone acetate orally on the hair root status in women with idiopathic hirsutism. Arch Dermatol Res 260:137–142PubMedCrossRefGoogle Scholar
  125. Peereboom-Wynia JDR, Boekhorst JC (1980) Effect of cyproterone acetate orally on hair density and diameter, and endocrine factors in women with idiopathic hirsutism. Dermatologica 160:7–16PubMedCrossRefGoogle Scholar
  126. Pinneil SR, Murad S (1987) Effects of minoxidil on cultured human skin fibroblasts. Dermatologica 175, Suppl 2:12–18CrossRefGoogle Scholar
  127. Pria SD, Greenblatt RB, Mahesh VB (1969) An antiandrogen in acne and idiopathic hirsutism. J Invest Dermatol 52:348–350PubMedGoogle Scholar
  128. Price VH (1975) Testosterone metabolism in the skin. Arch Dermatol 111:1496–1502PubMedCrossRefGoogle Scholar
  129. Rampini E, Bertamino R, Moretti G (1968) Size and shape of sebaceous glands in male pattern alopecia. In: Baccaredda-Boy A, Moretti G, Frey JR (eds) Biopathology of pattern alopecia. Karger, Basel, pp 155–165Google Scholar
  130. Ranchoff RE, Bergfeld WF (1985) Topical minoxidil reduces blood pressure. J Am Acad Dermatol 12:586–587PubMedCrossRefGoogle Scholar
  131. Raynaud JP, Bonne C, Bouton MM (1979) Action of a nonsteroidal antiandrogen, RU 23908, in peripheral and central tissue. J Steroid Biochem 11:93–95PubMedCrossRefGoogle Scholar
  132. Rentoul JR (1983) Management of the hirsute woman. Int J Dermatol 22:265–272PubMedCrossRefGoogle Scholar
  133. Rittmaster RS, Loriaux L (1987) Hirsutism. Ann Int Med 106:95–107Google Scholar
  134. Rittmaster RS, Uno H, Povar ML, Mellin TN, Loriaux DL (1987) The effects of N,N-diethyl4-methyl-3-oxo-4-aza-5a-androstane-17j5-carboxamide, a 5a-reductase inhibitor and antiandrogen, on the development of baldness in the stumptail macaque. J Clin Endocrinol 65:188–193Google Scholar
  135. Roenigk HH, Pepper E (1985) Topical minoxidil therapy for hereditary male pattern alopecia. Clin Res 33:914AGoogle Scholar
  136. Rook A (1977) Common baldness and alopecia areata. In: Rook A (ed) Recent advances in dermatology, vol 4. Churchill Livingstone, Edinburgh, pp 223–247Google Scholar
  137. Runne U, Martin H (1986) Veränderungen von Telogenrate, Haardichte, Haardurchmesser und Wachstumsgeschwindigkeit bei der androgene tischen Alopezie des Mannes. Hautarzt 37:198–204PubMedGoogle Scholar
  138. Rushton H, James KC, Mortimer CH (1983) The unit area trichogram in the asessment of an-drogen-dependent alopecia. Br J Dermatol 109:429–437PubMedCrossRefGoogle Scholar
  139. Rushton DH, Vuger WP, Cotterill PC, Kingsley P, James KC (1989) Quantitative assessment of 2% topical minoxidil in the treatment of male pattern baldness. Clin Exp Dermatol 14:40–46PubMedCrossRefGoogle Scholar
  140. Salamon T (1966) Vererbung von Haar- und Nagelkrankheiten. In: Jadassohn J (ed) Handbuch der Hautu. Geschlechtskrankheiten. Ergänzungswerk, vol VII. Springer, Berlin Heidelberg New York, pp 364–39Google Scholar
  141. Salamon T (1968) Genetic factors in male alopecia. In: Baccaredda-Boy A, Moretti G, Frey FR (eds) Biopathology of pattern alopecia. Karger, Basel, pp 39–49Google Scholar
  142. Sansone G, Reisner RM (1971) Differential rates of conversion of testosterone to dihydrotestosterone in acne and in normal human skin. A possible pathogenic factor in acne. J Invest Dermatol 56:366–372PubMedCrossRefGoogle Scholar
  143. Savin RC (1968) The ineffectiveness of testosterone in male pattern baldness. Arch Dermatol 98:512–514PubMedCrossRefGoogle Scholar
  144. Schein M (1903) Über die Entstehung der Glatze. Wien Klin Wochenschr 16:611–615Google Scholar
  145. Schmidt JB (1987) Nuclear and cytosol androgen receptor in androgen dependent dermatoses in female patients. Exp Clin Endocrinol 90:107–112PubMedCrossRefGoogle Scholar
  146. Schmidt JB, Huber J, Spona J (1985) Medroxyprogesterone acetate therapy in hirsutism. Br J Dermatol 113:161–165PubMedCrossRefGoogle Scholar
  147. Schmidt JB, Schurz B, Huber J, Spona J (1989) Hypothyreose und Hyperprolaktinämie als mögliche Ursache der androgenetischen Alopezie der Frau. Z Hautkr 64:9–12PubMedGoogle Scholar
  148. Schmidt JB, Spona J (1987) Ein wirksames topisches Antiandrogen. 17a-propylmesterolon bei Akne. Hautarzt 38:470–473PubMedGoogle Scholar
  149. Schumacher-Stock U, Winkler K (1977) Die externe Östrogentherapie der androgenetischen Alopezie. Hautarzt Suppl 11:336–338Google Scholar
  150. Schweikert HU, Wilson JD (1974) Regulation of human hair growth by steroid hormones. I. Testosterone metabolism in isolated hairs. J Clin Endocr Metab 38:811–819PubMedCrossRefGoogle Scholar
  151. Setty LR (1970) Hair patterns of the scalp of white and negro males. Am J Phys Anthropol 33:49–55PubMedCrossRefGoogle Scholar
  152. Sheehan-Dare RA, Hughes BR, Cunliffe WJ (1988) Clinical markers of androgenicity in acne vulgaris. Br J Dermatol 119:723–730PubMedCrossRefGoogle Scholar
  153. Shi Y-P (1986) Topical minoxidil in the treatment of alopecia areata and male pattern alopecia. Arch Dermatol 122:506PubMedCrossRefGoogle Scholar
  154. Silva PD, Gentzschein EEK, Lobo RA (1987) Androstenedione may be a more important precursor of tissue dihydrotestosterone than testosterone in women. Fert Steril 48:419–422Google Scholar
  155. Silvestri U (1967) Studio fisico del capello in casiusica de alopecia su base seborroica. Arch Ital Dermatol 34:405–409Google Scholar
  156. Smith MA, Wells RS (1964) Male type alopecia, alopecia areata and normal hair in women; family histories. Arch Dermatol 89:95–98PubMedCrossRefGoogle Scholar
  157. Steigleder GK, Mahrle G (1973) Haarausfall als polyätiologisches Symptom. In: Braun-Falco O, Petzold D (eds) Vorträge des 7. Fortbildungskurses. Springer, Berlin Heidelberg New York, pp 237–248 (Fortschritte der praktischen Dermatologie und Venerologie, vol 7)Google Scholar
  158. Storer JS, Brzuskiewicz J, Floyd H, Rice JC (1986) Review: topical minoxidil for male pattern baldness. Am J Med Sci 291:328–333PubMedCrossRefGoogle Scholar
  159. Sulzberger MB, Witten VH, Kopf AW (1960) Diffuse alopecia in women. Its unexplained apparent increase in incidence. Arch Dermatol 81:556–560PubMedCrossRefGoogle Scholar
  160. Takashima J (1974) Studies of common baldness in the stump-tailed macaque. V. Regional difference of testosterone metabolites in the hair follicles. Jpn J Derm 1:14–21Google Scholar
  161. Takashima J, Montagna W (1971) Studies of common baldness of the stump-tailed macaque (Macaca speciosa). VI. The effect of testosterone on common baldness. Arch Dermatol 103:527–534PubMedCrossRefGoogle Scholar
  162. Takayasu S, Wakimoto H, Hami S, Sano S (1980) Activity of testosterone 5a-reductase activity in various tissues of human skin. J Invest Dermatol 74:187–191PubMedCrossRefGoogle Scholar
  163. Tamm J, Volkwein U, Tresguerres JAF (1980) Plasma testosterone glucosiduronate: a reliable indicator of female hyperandrogenism. Clin Endocrin 13:431–435CrossRefGoogle Scholar
  164. Tamm J, Seckelmann M, Volkwein U, Ludwig E (1982) The effect of the antiandrogen lla-hydroxyprogesterone on sebum production and cholesterol concentration of sebum. Br J Dermatol 107:63–70PubMedCrossRefGoogle Scholar
  165. Thiele FAJ (1975) Chemical aspects of hair loss and its cosmetological significance. Br J Dermatol 92:355–358PubMedCrossRefGoogle Scholar
  166. Tosti A (1986) Topical minoxidil useful in 18% of patients with androgenetic alopecia: a study of 430 cases. Dermatologica 173:136–138PubMedCrossRefGoogle Scholar
  167. Tosti A, Bardazzi F, De Padova MP, Caponeri GM, Medino M, Veronesi S (1985) Contact dermatitis to minoxidil. Contact Dermatitis 13:275–276PubMedCrossRefGoogle Scholar
  168. Uno H, Adachi K, Montagna W (1969) Baldness of the red macari. Histological properties and enzyme activities of hair follicles. J Geront 24:23–27PubMedGoogle Scholar
  169. Uno H, Cappas A, Brigham PA (1984) Transformation of hair follicles and the therapeutic effect of minoxidil on the bald scalp of stump-tailed macaques (macaca arctoides). Chronic Derm AXVI no 4/85. Atti XXIII Congr Naz ADOI, Sorrento 1984, pp 565–583Google Scholar
  170. Uno H, Cappas A, Schlägel C (1985) Cyclis dynamics of hair follicles and the effect of minoxidil on the bald scalps of stump-tailed macaques. Am J Dermatolpathol 7:283–297CrossRefGoogle Scholar
  171. Vanderveen EE, Ellis CN, Kang S, Case P, Headington JT, Voorhees JJ (1984) Topical minoxidil for hair regrowth. J Am Acad Dermatol 11:416–121PubMedCrossRefGoogle Scholar
  172. Van der Willigen AH, Peerboom-Wynia GDR, Van Joost T, Stolz E (1987) A preliminary study of lla-hydroxyprogesterone on the hair growth in men suffering from androgenetic alopecia. Acta Derm Venereol 67:82–85PubMedGoogle Scholar
  173. Van Scott EJ, Reinertson RP, Steinmuller R (1957) The growing hair roots in the human scalp and morphological changes therein following amethopterin therapy. J Invest Dermatol 29:197–204Google Scholar
  174. Venning VA, Dawber RPR (1988) Patterned androgenic alopecia in women. J Am Acad Dermatol 18:1073–1077PubMedCrossRefGoogle Scholar
  175. Verbov JL (1978) Common baldness occurring in females only, in one generation. Br J Clin Pract 32:261–262PubMedGoogle Scholar
  176. Vermorken AJM (1983) Reversal of androgenic alopecia by minoxidil: lack of effect of simultaneously administered doses of cyproterone acetate. Acta Dermato Venereol 63:268–269Google Scholar
  177. Weiss VC, West DP, Fu TS, Robinson LA, Cook B et al. (1984) Alopecia areata treated with topical minoxidil. Arch Dermatol 120:457–163PubMedCrossRefGoogle Scholar
  178. Weissmann A, Bowden J, Frank L, Horwitz S, Frost P (1985) Antiandrogenic action of topically applied spironolactone on the hamster flank organ. Arch Dermatol 121:57–62PubMedCrossRefGoogle Scholar
  179. Wendker H, Schaefer H, Zesch A (1976) Penetrationskinetik und Verteilung lokal applizierter Östrogene. Arch Dermatol Res 256:67–74PubMedCrossRefGoogle Scholar
  180. Wester RC, Maibach HI, Guy RH, Novak E (1984) Minoxidil stimulates cutaneous blood flow in human balding scalps. Pharmacodynamics measured by laser Doppler velocimetry and photopulse plethysmography. J Invest Dermatol 82:515–517PubMedCrossRefGoogle Scholar
  181. White SI, Friedman PS (1985) Topical minoxidil lacks efficacy in alopecia areata. Arch Dermatol 121:591PubMedCrossRefGoogle Scholar
  182. Winkler K (1971) Der Einfluß von Hormonen, im besonderen von Antiandrogenen, auf Seborrhoe und Haarwachstum. Zentralbl Haut Geschl Krk 46:76–78Google Scholar
  183. Wüstner H, Orfanos CE (1974) Alopecia androgenetica und ihre Lokalbehandlung mit östrogen-und corticoidhaltigen Externa. Z Hautkr 49:879–888PubMedGoogle Scholar
  184. Zappacosta AR (1980) Reversal of baldness in a patient receiving minoxidil for hypertension. N Engl J Med 303:1480PubMedGoogle Scholar
  185. Zarate A, Mahes VB, Greenblatt RB (1966) Effect of an antiandrogen, 17a-methyl-/?-nortestos-terone, on acne and hirsutism. J Clin Endocr 26:1394–1398PubMedCrossRefGoogle Scholar
  186. Zaun H (1969) Wachstumsstörungen der Kopfhaare als Folge von Hepatopathien. Arch Klin Exp Dermatol 235:386–393CrossRefGoogle Scholar
  187. Zaun H (1970) Über den Einfluß einiger ovulationshemmender Hormonkombinationen auf das Wachstum der Haare. Dtsch Med Wochenschr 95:1433–1436PubMedCrossRefGoogle Scholar
  188. Zaun H (1971) Ovulationshemmer als Behandlung der androgenetischen Alopecie bei der Frau. Hautarzt 22:594Google Scholar
  189. Zaun H (1973) Haarwuchsstörungen nach Sexualhormontherapie bei Haarwuchsstörungen. Hautarzt 24:1–6PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

There are no affiliations available

Personalised recommendations